Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
price target cut at Citi to $12 from $15 after FDA did not approve lluvien NDA. Maintain Buy rating.
target increased at Kaufman to $690. Company should benefit from strong domestic online holiday sales.
estimates, target raised at Wedbush. Shares of ROVI now seen reaching $59, according to Wedbush Securities. Estimates also increased, to match the company's new guidance, following the SNIC acquisition.
Time Warner Cable
target boosted at Argus to $75. Company is leveraged to benefit from a recovery in the economy. Buy rating.
This article was written by a staff member of TheStreet.